| Antibodies - Researchers develop new antibody with potential to treat several types of cancer |
|
|
|
|
| |
|
|
| |
The latest antibodies news from News Medical |
|
|
|
 | | |
 Unlock Monoclonal Antibody Production with RedShift BioAnalytics e- Book
Explore the latest advancements in monoclonal antibody production with this e-book.
Discover key challenges in bioprocessing, how the HaLCon Analyzer revolutionizes real-time titer measurement, enhancing efficiency and reducing costs. Learn from industry experts and access additional resources to streamline your bioproduction processes.
| |
|
|
|
|
| | |  During the COVID pandemic, many of us have received multiple mRNA vaccines. New work by researchers at the VIB-UGent Center for Inflammation Research, Ghent University, and University Hospital Ghent, among others, has found that such repeated vaccinations lead to the presence of mucosal antibodies, for example, inside the nose. Their work appears in Science Translational Medicine. | | | | |  Scientists at the Icahn School of Medicine at Mount Sinai, in collaboration with colleagues in the field, have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade existing vaccines and therapies. | | | | |  Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy that combines the precision of monoclonal antibodies with the potency of cytotoxic drugs. | |
|
|
|
|
| | | How would you rate today's newsletter?
| |
|
|
|
 | | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|
|
